Skip to main content

Vivani Medical, Inc.

corporate_fare Company Profile

Vivani Medical, Inc.

VANI·NASDAQ·Industrial Applications And Services·CIK 0001266806

Vivani Medical, Inc. is a clinical stage biopharmaceutical company that develops miniature, ultra long-acting subdermal drug implant candidates. The company utilizes its proprietary NanoPortal™ technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop and potentially commercialize drug implant candidates, either independently or in collaboration with pharmaceutical company partners. These candidates aim to address leading causes of poor clinical outcomes in chronic disease treatment, such as medication non-adherence, drug tolerability, and administration challenges. According to the U.S. Centers for Disease Control and Prevention, adherence refers to how well an individual's behavior, including taking medications, aligns with healthcare provider recommendations. Approximately 50% of patients do not or cannot take their medicine as prescribed, a statistic applicable to both daily oral and weekly injectable medicines. For instance, a recent study indicated that 64% of patients taking Wegovy® (semaglutide injection) discontinue treatment within the first year, increasing to 76% by the second year. GLP-1 discontinuation can lead to failure in achieving target outcomes and a rapid reversal of health benefits for most patients. Vivani is developing a portfolio of miniature, ultra long-acting subdermal drug implant candidates based on its NanoPortal technology. These implants are designed to guarantee medication adherence by delivering therapeutic drug levels for up to six months or longer, unlike most oral and injectable medicines. The NanoPortal implant technology has the potential to allow patients to maintain continuous and therapeutic drug exposure levels with convenient once or twice yearly administration, and the option to stop therapy at any time by removing the implant.

Vivani Medical, Inc. (NASDAQ:VANI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 30 items for VANI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for VANI spans 10-Q, 8-K, 4, SCHEDULE 13D/A.

Recent high-impact activity:

  • Board Members Buy $5.1M of Stock at $1.01 in Insider-Led Private Placement
  • Vivani 10-Q: Going Concern Warning, Cash Runway Only Through Q1 2027
  • SLIM-1 Data: Semaglutide Implant Matches Wegovy Weight Loss With Zero Treatment-Related AEs
  • Vivani Posts $7.3M Q3 Loss, Confirms SLIM-1 Implant Data Due This Week
  • Vivani Medical Flags Going Concern, Cash Runs Out by Q2 2027

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$26.61M
Diluted EPS
-$0.43
Op. Cash Flow
-$24.32M
Free Cash Flow
-$25.49M
Operating Income
-$27.56M
Cash & Equivalents
$16.23M
Debt / Equity
0.00×
Shares Outstanding
76.43M sh
Source: 10-K · filed 2026-03-26 · accession 0001753926-26-000548

Short Interest & Short Volume

2.03 days to cover

FINRA reported short interest of 369,789 shares in VANI as of the October 30, 2026 settlement, a 11.3% decrease from the prior period — about 2.0 days to cover at its recent average daily volume. On November 20, 2026, 43.2% of VANI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)369,789 shares as of October 30, 2026
Change vs prior period▼ 11.3%
Days to cover2.03 at avg daily volume of 181,963
Daily short volume (FINRA facilities)43.2% of 247,551 shares on November 20, 2026
5-day average short volume34.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with V →
$1.14
52-week range · as of 2026-11-12 $0.9227 – $1.66
Market cap
$102.83M
Volume
449K (1.7× avg)
3-mo avg 258.1K
Live data · 2026-11-22 12:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed VANI - Latest Insights

VANI
Nov 16, 2026, 5:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $1.14 info
Change: +$0.090 (+9%) info
Market Cap: $102.832M info
VANI
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $1.14 info
Change: -$0.0418 (-4%) info
Market Cap: $102.832M info
VANI
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.14 info
Change: -$0.030 (-3%) info
Market Cap: $102.832M info
VANI
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.14 info
Change: +$0.010 (+0.88%) info
Market Cap: $102.832M info
VANI
Aug 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $1.14 info
Change: -$0.200 (-15%) info
Market Cap: $102.832M info
VANI
Aug 06, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $1.14 info
Change: -$0.260 (-19%) info
Market Cap: $102.832M info
VANI
Jul 16, 2026, 9:00 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $1.14 info
Change: -$0.270 (-19%) info
Market Cap: $102.832M info
VANI
Jul 16, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $1.14 info
Change: -$0.2939 (-20%) info
Market Cap: $102.832M info
VANI
Jul 07, 2026, 7:46 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $1.14 info
Change: -$0.380 (-25%) info
Market Cap: $102.832M info
VANI
Jul 07, 2026, 7:35 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.42
Real-time Price: $1.14 info
Change: -$0.2802 (-20%) info
Market Cap: $102.832M info
VANI
Jun 30, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $1.14 info
Change: -$0.1003 (-8%) info
Market Cap: $102.832M info
VANI
Jun 25, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $1.14 info
Change: -$0.100 (-8%) info
Market Cap: $102.832M info
VANI
Jun 16, 2026, 9:00 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $1.15
Real-time Price: $1.14 info
Change: -$0.010 (-0.87%) info
Market Cap: $102.832M info
VANI
Jun 04, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $1.14 info
Change: -$0.100 (-8%) info
Market Cap: $102.832M info
VANI
May 19, 2026, 1:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.18
Real-time Price: $1.14 info
Change: -$0.035 (-3%) info
Market Cap: $102.832M info
VANI
May 19, 2026, 8:31 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.14
Real-time Price: $1.14 info
Change: $0 (0%) info
Market Cap: $102.832M info
VANI
May 13, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $1.14 info
Change: -$0.0187 (-2%) info
Market Cap: $102.832M info
VANI
May 13, 2026, 4:24 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $1.14 info
Change: -$0.0187 (-2%) info
Market Cap: $102.832M info
VANI
May 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $1.14 info
Change: -$0.020 (-2%) info
Market Cap: $102.832M info
VANI
Apr 29, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $1.14 info
Change: -$0.180 (-14%) info
Market Cap: $102.832M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets